AdamJBassMD

PubMed

• 1 citations
  RHOAdrives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling.
  Diehl, J. N., Antje Schaefer, Richard G Hodge, Haisheng Zhang, G Aaron Hobbs, Julien Dilly, Minh V Huynh, Craig M Goodwin, Feifei Zhang, J Nathaniel Diehl, Mariaelena ...> ;Science Signaling. 2023 Dec 19
• 3 citations
  Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinoma.
  Stachler, M. D., Stachler, M. D., Chunyang Bao, Richard W Tourdot, Gregory J Brunette, Chip Stewart, Lili Sun, Hideo Baba, Masayuki Watanabe, Agoston T Agoston, Kunal ...> ;Nature Communications. 2023 Oct 4
• 1 citations
  Developing SHP2-based combination therapy for KRAS-amplified cancer.
  Tianxia Li, Osamu Kikuchi, Jin Zhou, Yichen Wang, Babita Pokharel, Klavdija Bastl, Prafulla Gokhale, Aine Knott, Yanxi Zhang, John G Doench, Zandra V Ho, Daniel Vt Cat...> ;JCI Insight. 2023 Feb 8
• 5 citations
  Corrigendum to "Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma": [Annals of Oncology 33 (2022) 1134-1148].
  J E Augustin, P Soussan, A J Bass> ;Annals of Oncology. 2023 Jul 1
• 5 citations
  Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.
  Walid K Chatila, Henry Walch, Jaclyn F Hechtman, Sydney M Moyer, Valeria Sgambati, David M Faleck, Amitabh Srivastava, Laura Tang, Jamal Benhamida, Dorina Ismailgeci, ...> ;Nature Communications. 2023 Jan 7
• 2 citations
  Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
  Rachel B Keller, Tali Mazor, Lynette Sholl, Andrew J Aguirre, Harshabad Singh, Nilay Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor Hennessey, M...> ;JCO Precision Oncology. 2023 Jan 1
• 11 citations
  KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.
  Yuanwang Pan, Han Han, Hai Hu, Hua Wang, Yueqiang Song, Yuan Hao, Xinyuan Tong, Ayushi S Patel, Selim Misirlioglu, Sittinon Tang, Hsin-Yi Huang, Ke Geng, Ting Chen, An...> ;Cancer Cell. 2023 Jan 9
• 3 citations
  Clinical and Genomic Characterization of Interval Colorectal Cancer in 3 Prospective Cohorts.
  Yang, K., Cao, Y., Gurjao, C., Liu, Y., Guo, C., Lo, C., Zong, X., Drew, D., Geraghty, C., Prezioso, E., Moore, M., Williams, C., Riley, T., Saul, M., Ogino, S., Giann...> ;Gastroenterology. 2022 Dec 1
• 2 citations
  Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation.
  Bartosz Mucha, Shuo Qie, Sagar Bajpai, Vincenzo Tarallo, J Nathaniel Diehl, Frank Tedeschi, Gao Zhou, Zhaofeng Gao, Samuel Flashner, Andres J Klein-Szanto, Hanina Hibs...> ;Nature Communications. 2022 Nov 3
• 2 citations
  Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer.
  Ke Peng, Feifei Zhang, Yichen Wang, Pranshu Sahgal, Tianxia Li, Jin Zhou, Xiaoyan Liang, Yanxi Zhang, Nilay Sethi, Tianshu Liu, Haisheng Zhang, Adam J Bass> ;Clinical Cancer Research. 2023 Jan 4
• 5 citations
  Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma.
  J E Augustin, P Soussan, A J Bass> ;Annals of Oncology. 2022 Nov 1
• 7 citations
  Adenocarcinoma of the oesophagus: is it gastric cancer?
  Michael Quante, Timothy C Wang, Adam J Bass> ;Gut. 2023 Jun 1
• 9 citations
  Transcription factor-mediated intestinal metaplasia and the role of a shadow enhancer.
  Harshabad Singh, Davide Seruggia, Shariq Madha, Madhurima Saxena, Ankur K Nagaraja, Zhong Wu, Jin Zhou, Aaron J Huebner, Adrianna Maglieri, Juliette Wezenbeek, Konrad ...> ;Genes & Development. 2022 Jan 1
• 9 citations
  A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer.
  Yanli Liu, Zhong Wu, Jin Zhou, Dinesh K A Ramadurai, Katelyn L Mortenson, Estrella Aguilera-Jimenez, Yifei Yan, Xiaojun Yang, Alison M Taylor, Katherine E Varley, Jaso...> ;Nature Communications. 2021 Dec 8
• 14 citations
  Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancer.
  Tatiana A. Karakasheva, Joel Gabre, Uma M. Sachdeva, Ricardo Cruz-Acuna, Eric W. Lin, Maureen DeMarshall, Gary W. Falk, Gregory G. Ginsberg, Zhaohai Yang, Michele M. K...> ;Scientific Reports. 2021 Oct 29
• 28 citations
  Abnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia.
  Mark Redston, Amy Noffsinger, Anthony Kim, Fahire G Akarca, Marianne Rara, Diane Stapleton, Laurel Nowden, Richard H. Lash, Adam J. Bass, Matthew D. Stachler> ;Gastroenterology. 2021 Oct 29
• 5 citations
  BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model.
  Ye He, Joshua Rivera, Miklos Diossy, Haohui Duan, Christian Bowman-Colin, Rachel Reed, Rebecca B. Jennings, Jesse Novak, Stevenson V Tran, Elizabeth F Cohen, Dávid Szü...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Oct 12
• 18 citations
  An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
  Xiaoyan Liang, Gina N. Duronio, Yaying Yang, Pratyusha Bala, Prajna Hebbar, Sándor Spisák, Pranshu Sahgal, Harshabad Singh, Yanxi Zhang, Yingtian Xie, Paloma Cejas, He...> ;Gastroenterology. 2021 Sep 25
• 19 citations
  Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer.
  Fabin Dang, Li Nie, Jin Zhou, Kouhei Shimizu, Chen Chu, Zhong Wu, Anne Fassl, Shizhong Ke, Yuangao Wang, Jinfang Zhang, Tao Zhang, Zhenbo Tu, Hiroyuki Inuzuka, Piotr S...> ;Nature Communications. 2021 Sep 10
• 12 citations
  Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival.
  Leonie K. de Klerk, Anuj K. Patel, Sarah Derks, Eirini Pectasides, Jeremy Augustin, Mohamed Uduman, Nihal Raman, Fahire G Akarca, Nadine Jackson McCleary, James M. Cle...> ;Journal for Immunotherapy of Cancer. 2021 Sep 1
• Florid Foreign Body-type Giant Cell Response to Keratin Is Associated With Improved Overall Survival in Patients Receiving Preoperative Therapy for Esophageal Squamous...
  Wei Chen, Lei Zhao, Agoston T. Agoston, Abby White, Emanuele Mazzola, Patrick J. Boyle, Vikram Deshpande, Jason L. Hornick, Raphael Bueno, Adam J. Bass, Peter C. Enzin...> ;The American Journal of Surgical Pathology. 2021 Dec 1
• 35 citations
  Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.
  Zhong Wu, Jin Zhou, Xiaoyang Zhang, Zhouwei Zhang, Yingtian Xie, Jie Bin Liu, Zandra V. Ho, Arpit Panda, Xintao Qiu, Paloma Cejas, Israel Cañadas, Fahire G Akarca, Jam...> ;Nature Genetics. 2021 May 10
• 10 citations
  Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma.
  Jin Zhou, Zhong Wu, Zhouwei Zhang, Louisa B Goss, James M. McFarland, Ankur K. Nagaraja, Yingtian Xie, Shengqing Gu, Ke Peng, Yong Zeng, Xiaoyang Zhang, Henry W. Long,...> ;Gut. 2021 Mar 31
• 9 citations
  Mutant p53 regulates Survivin to foster lung metastasis.
  Qiaosi Tang, Gizem Efe, Anna M. Chiarella, Jessica C. Leung, Maoting Chen, Taiji Yamazoe, Zhenyi Su, Jason R. Pitarresi, Jinyang Li, Mirazul Islam, Tatiana A. Karakash...> ;Genes & Development. 2021 Apr 1
• 5 citations
  Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies.
  Leonie K. de Klerk, Ruben S. A. Goedegebuure, Nicole C.T. van Grieken, Johanna W. van Sandick, Annemieke Cats, Jurriën Stiekema, Rosa T. van der Kaaij, Arantza Farina ...> ;Molecular Oncology. 2021 Apr 1
• Join now to see all

Journal Articles

• Author Correction: Targeting Wild-Type KRAS-Amplified Gastroesophageal Cancer Through Combined MEK and SHP2 Inhibition  
  Daniel Catenacci, Adam J Bass, Shaunt Fereshetian, Rameen Beroukhim, Nature
• Comprehensive Molecular Characterization of Clinical Responses to PD-1 Inhibition in Metastatic Gastric Cancer  
  Adam Bass, MD, Nature